Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A. Braun(Yale Cancer Center), Toni K. Choueiri(Harvard University), David F. McDermott(Beth Israel Deaconess Medical Center), Petra Ross‐Macdonald(Bristol-Myers Squibb (United States)), Jean‐Christophe Pignon(Brigham and Women's Hospital), Ziad Bakouny(Dana-Farber Cancer Institute), Andrew D. Cherniack(Broad Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Yue Hou(Inner Mongolia Medical University), Arlene H. Sharpe(Brigham and Women's Hospital), John A. Steinharter(Memorial Sloan Kettering Cancer Center), Sabina Signoretti(Brigham and Women's Hospital), Catherine J. Wu(Dana-Farber Cancer Institute), Miriam Sant’ Angelo(Brigham and Women's Hospital), Miriam Ficial(Barts Health NHS Trust), Maxine Sun(Université de Montréal), Gordon J. Freeman(Dana-Farber Cancer Institute), Sachet A. Shukla(Broad Institute), Liudmilla Elagina(Broad Institute), Paul Catalano(Harvard University), Opeyemi A. Jegede(Dana-Farber Cancer Institute), Megan Wind‐Rotolo(Bristol-Myers Squibb (United States)), Lee Lichtenstein(Broad Institute), Ashton C. Berger(University of Florida), Juliet Forman(Broad Institute), Donna Neuberg(Otsuka (Japan))
Cited by 1,019
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k